Idea principal
Mendelian randomization using genetic predisposition to type 2 diabetes and higher HbA1c found associations with higher risk of any ischemic stroke, large artery stroke and small vessel stroke, plus markers of brain small-vessel disease and atrophy. The abstract gives no effect sizes, and the method relies on assumptions about genetic variants that cannot be fully verified.
Study design
Artículo de investigación
Reading basis
Published abstract
Reading focus
Design & applicability
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
People with type 2 diabetes have more strokes, but it is hard to tell which part of the disease is responsible, because lifestyle and other conditions overlap. The authors used genetic variants as natural experiments to test whether predisposition to diabetes, high glucose, insulin resistance or beta-cell dysfunction affects stroke subtypes and related brain changes.
Población y método
Two-sample Mendelian randomization using instruments from published genome-wide association studies: type 2 diabetes (74,124 cases, 824,006 controls), HbA1c (n = 421,923), fasting glucose (n = 133,010), insulin resistance (n = 108,557) and beta-cell dysfunction (n = 16,378). Outcomes were ischemic stroke (60,341 cases, 454,450 controls), intracerebral hemorrhage (1,545 cases, 1,481 controls), ischemic stroke subtypes (large artery, cardioembolic, small vessel), carotid atherosclerosis, white matter integrity imaging markers and brain atrophy.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Genetic predisposition to type 2 diabetes and higher HbA1c was associated with higher risk of any ischemic stroke, large artery stroke and small vessel stroke.
- 2Similar associations were seen for carotid atherosclerotic plaque, fractional anisotropy (a white matter disease marker) and markers of brain atrophy.
- 3Genetic predisposition to insulin resistance was associated with large artery and small vessel stroke.
- 4Predisposition to beta-cell dysfunction was associated with small vessel stroke, intracerebral hemorrhage, lower gray matter volume and lower total brain volume.
Límites e incertidumbre
- 1The abstract gives no effect sizes, confidence intervals or P values, so the strength of each association cannot be judged.
- 2Mendelian randomization assumes the genetic variants affect stroke only through the exposure; this cannot be fully checked, and the authors' causal wording rests on that assumption.
- 3The intracerebral hemorrhage sample was small (1,545 cases), and the beta-cell dysfunction instrument was based on only 16,378 people.
- 4Results reflect lifelong genetic differences, not what happens when someone lowers glucose later in life.
Relevancia práctica
This adds evidence that high glucose over a lifetime contributes to the most common kinds of stroke, which supports taking diabetes and glucose control seriously. It does not tell you how much a change in your own glucose will alter your stroke risk; treatment decisions belong with your clinician.
Tus datos
Relevant personal data include HbA1c from lab tests, fasting glucose from a meter or CGM, and blood pressure. Compare trends across months using the same method and conditions, and share them with your clinician rather than acting on single readings.
Cómo interpretar la evidencia
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Objective
We employed Mendelian randomization to explore the effects of genetic predisposition to type 2 diabetes (T2D), hyperglycemia, insulin resistance, and pancreatic β-cell dysfunction on risk of stroke subtypes and related cerebrovascular phenotypes.
Methods
We selected instruments for genetic predisposition to T2D (74,124 cases, 824,006 controls), HbA1c levels (n = 421,923), fasting glucose levels (n = 133,010), insulin resistance (n = 108,557), and β-cell dysfunction (n = 16,378) based on published genome-wide association studies. Applying 2-sample Mendelian randomization, we examined associations with ischemic stroke (60,341 cases, 454,450 controls), intracerebral hemorrhage (1,545 cases, 1,481 controls), and ischemic stroke subtypes (large artery, cardioembolic, small vessel stroke), as well as with related phenotypes (carotid atherosclerosis, imaging markers of cerebral white matter integrity, and brain atrophy).
Results
Genetic predisposition to T2D and higher HbA1c levels were associated with higher risk of any ischemic stroke, large artery stroke, and small vessel stroke. Similar associations were also noted for carotid atherosclerotic plaque, fractional anisotropy, a white matter disease marker, and markers of brain atrophy. We further found associations of genetic predisposition to insulin resistance with large artery and small vessel stroke, whereas predisposition to β-cell dysfunction was associated with small vessel stroke, intracerebral hemorrhage, lower gray matter volume, and total brain volume.
Conclusions
This study supports causal effects of T2D and hyperglycemia on large artery and small vessel stroke. We show associations of genetically predicted insulin resistance and β-cell dysfunction with large artery and small vessel stroke that might have implications for antidiabetic treatments targeting these mechanisms.
Classification of evidence
This study provides Class II evidence that genetic predisposition to T2D and higher HbA1c levels are associated with a higher risk of large artery and small vessel ischemic stroke.
Fuentes y atribución
Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study.
Georgakis MK, Harshfield EL, Malik R, Franceschini N, Franceschini N, Langenberg C, Wareham NJ, Markus HS, Dichgans M.
Neurology · 2021-01-25
DOI: 10.1212/wnl.0000000000011555 ↗PubMed · 33495378 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

